The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration
Current Drug Target -CNS & Neurological Disorders · 2002
DOI: 10.2174/1568007023339166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -CNS & Neurological Disorders, 2002. Verfasst von M J O'Neill und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly and Co. Ltd., Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey GU20 6PH, UK. ONEILL_MICHAEL_J@Lilly.Com. Die Arbeit wurde bisher 149-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Eli Lilly and Co. Ltd., Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey GU20 6PH, UK. ONEILL_MICHAEL_J@Lilly.Com
Zitieren
APA
O'Neill, M. J., Murray, T. K., Lakics, V., Visanji, N. P., & Duty, S. (2002). The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration. Current Drug Target -CNS & Neurological Disorders. https://doi.org/10.2174/1568007023339166
Vancouver
O'Neill MJ, Murray TK, Lakics V, Visanji NP, Duty S. The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration. Current Drug Target -CNS & Neurological Disorders. 2002. doi:10.2174/1568007023339166
BibTeX
@article{ONeill2002,
author = {O'Neill, M J and Murray, T K and Lakics, V and Visanji, N P and Duty, S},
title = {The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration},
journal = {Current Drug Target -CNS & Neurological Disorders},
year = {2002},
doi = {10.2174/1568007023339166}
}
EUVIMED